Hyderabad-based start-up Acubiosys, incubated at the Centre for DNA Fingerprinting and Diagnostics (CDFD), has launched AI-driven, nanotechnology-enabled plant-based medicines for psoriasis and diabetic inflammation.
The findings, presented at the European Academy of Dermatology and Venereology (EADV) Congress 2023 in Berlin, Germany, showed that the sleep disturbances were found to have broader implications on patients' quality of life.
